DreamCIS

DreamCIS FCF Yield

The Free Cash Flow Yield of DreamCIS (223250.KQ) as of Oct 29, 2026 is 9.45 %. In the previous year, Free Cash Flow Yield was -1.11 % — a change of -949.62% (higher).

FCF Yield

9.45 %

YoY

-949.62%

Last updated:

Free Cash Flow Yield of DreamCIS is 2025 9.45 % . Free Cash Flow Yield of DreamCIS was 2024 -1.11 % . It decreases by -949.62% higher compared to the previous year.

The DreamCIS FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
3.38 KRW
Jan 1, 2019
2.98 KRW
Jan 1, 2020
2.22 KRW
Jan 1, 2021
3.36 KRW
Jan 1, 2022
5.96 KRW
Jan 1, 2023
3.98 KRW
Jan 1, 2024
-1.11 KRW
Jan 1, 2025
9.45 KRW
The DreamCIS FCF Yield history
YEARFCF YieldYoY
9.45 %-949.62%
-1.11 %-127.93%
3.98 %-33.22%
5.96 %+77.50%
3.36 %+51.47%
2.22 %-25.56%
2.98 %-11.83%
3.38 %+190.39%
1.16 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DreamCIS Stock analysis

What does DreamCIS do? DreamCIS Inc. is a company based in Seoul, South Korea, operating within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company went public on May 22, 2020, with its stock listed under the ticker 223250.KQ and ISIN KR7223250002. DreamCIS Inc. provides clinical online information and consultation services, focusing on regulatory post-marketing surveillance (rPMS), clinical trials, and non-interventional studies (NIS). The company serves both domestic and international markets, offering its services to clients seeking support in clinical research and regulatory compliance. Its headquarters are located in Seoul, South Korea. The company's website is http://www.dreamcis.com/, which serves as a primary source for further information about its services and operations. DreamCIS Inc. does not provide detailed information about its founding year, specific leadership, or financial figures beyond its IPO date, and no acquisitions or additional product names are mentioned in the provided data. The company's services are primarily aimed at facilitating clinical research and ensuring adherence to regulatory standards in the life sciences sector. DreamCIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DreamCIS stock

Free Cash Flow Yield of DreamCIS is 9.45 % in 2025.

Free Cash Flow Yield of DreamCIS changed from -1.11 % to 9.45 %, representing a -949.62% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield DreamCIS since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's DreamCIS with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — DreamCIS

All Key Metrics — DreamCIS